SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-046793
Filing Date
2024-04-12
Accepted
2024-04-12 16:27:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2411708d2_424b5.htm 424B5 416115
2 GRAPHIC tm2411708d2_424b5img001.jpg GRAPHIC 6445
3 GRAPHIC tm2411708d2_424b5img003.jpg GRAPHIC 14297
4 GRAPHIC tm2411708d2_424b5img002.jpg GRAPHIC 6431
  Complete submission text file 0001104659-24-046793.txt   455215
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-278340 | Film No.: 24841829
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)